New radioactive 'Smart Bomb' targets Hard-to-Treat cancers
NCT ID NCT05706129
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study is testing a new way to find and treat several types of advanced solid tumors, including kidney, pancreatic, and colorectal cancers. It uses a special radioactive compound that attaches to a protein found on these cancer cells. The study has multiple parts: first, to see if the imaging agent is safe and can spot tumors; then, to find the best dose of the treatment version; and finally, to check if the treatment shrinks tumors. About 270 adults with cancers that have spread or cannot be removed by surgery will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CANCER (CCRCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HM - Hopital de la Timone
RECRUITINGMarseille, 13005, France
-
CHRU de Nancy - Hopitaux de Brabois
RECRUITINGVandœuvre-lès-Nancy, 54511, France
-
CHU de Grenoble-Alpes, Boulevard de la Chantourne
RECRUITINGGrenoble, 38043, France
-
CHU de Nantes
RECRUITINGNantes, 44093, France
-
Centre Georges François Leclerc
RECRUITINGDijon, 21079, France
-
Centre Jean Perrin
RECRUITINGClermont-Ferrand, 63011, France
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
-
IUCT - Oncopole
RECRUITINGToulouse, 31100, France
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, VIC 3000, Australia
-
UNSW Sydney, St Vincent's Hospital Sydney
RECRUITINGSydney, NSW 2010, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- Can a Custom-Made vaccine outsmart Triple-Negative breast cancer?
- Can a drug combo outsmart a tough breast cancer subtype?
- A simple blood draw could spot bladder Cancer's return
- Can a new drug combo outsmart triple-negative breast cancer?